The bodies that clear a change in India's drug rules
Background
An amendment to the Drugs Rules, 1945 proposed this week shows how medicine regulation is changed in India.
A proposal is examined by the Drugs Technical Advisory Board, the technical body constituted under the drugs law to advise the Central Government, which took up the bulk drug licensing proposal at its 93rd meeting.
It also goes to the Drugs Consultative Committee, which brings the Centre and the State drug controllers to a common view, and which agreed to the same proposal at its 67th meeting.
The Ministry of Health and Family Welfare then proposes the amendment, and the change is worked into the rules themselves.
Licences for the wholesale of medicines are issued on forms prescribed in the rules, so a new category of licence brings a new application form and a new licence form with it: here Form 19-BC for the application and Form 20-BC for the licence.
The licence is to record the categories of bulk drugs a wholesaler handles, including those covered by the Narcotic Drugs and Psychotropic Substances Act, 1985, and sale is to be under the personal supervision of a competent person.
Existing licensees get time to comply: the new requirements apply on the expiry of their current retention period or twelve months after the final publication of the amendment, whichever is later.